• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

joe.zhu@unimelb.edu.au

Credentials


Position
Honorary Conjoint Senior Fellow
The Sir Peter MacCallum Department of Oncology
ORCID

0000-0003-4416-7040

Dr Joe Zhu

Honorary Conjoint Senior Fellow
The Sir Peter MacCallum Department of Oncology

32 Scholarly works
0 Projects

HIGHLIGHTS

  • 2026

    Journal article

    ENHANCING CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPY FOR PAEDIATRIC SARCOMA THROUGH CAR T ENGINEERING AND TUMOUR MICROENVIRONMENT REWIRING
    DOI: 10.1016/j.jcyt.2026.102225
  • 2025

    Conference Proceedings

    Development of a novel CAR-T cell therapy using a multimodal approach to target T cell lymphoma
    DOI: 10.1182/blood-2025-4112
  • 2025

    Journal article

    Personalized Immunotherapy for T Cell Lymphomas: From Immune Escape to Precision Therapeutics
    DOI: 10.3390/jpm15110560
  • 2025

    Journal article

    A novel switch receptor enhances CAR-T cell fitness in TGF-β-enriched solid tumors 3396
    DOI: 10.1093/jimmun/vkaf283.1207
  • 2024

    Conference Proceedings

    309 Engineering a novel switch receptor enhances CAR-T cell fitness in suppressive TGF-β-enriched solid tumors
    DOI: 10.1136/jitc-2024-sitc2024.0309
  • 2024

    Journal article

    Efficient generation of human NOTCH ligand-expressing haemogenic endothelial cells as infrastructure for in vitro haematopoiesis and lymphopoiesis
    DOI: 10.1038/s41467-024-51974-7
  • 2024

    Journal article

    FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy
    DOI: 10.1038/s41586-024-07242-1
Joe Zhu

RECENT SCHOLARLY WORKS

  • 2023

    Journal article

    Low-dose carboplatin modifies the tumor microenvironment to augment CAR T cell efficacy in human prostate cancer models
    DOI: 10.1038/s41467-023-40852-3
  • 2023

    Conference Proceedings

    Modifying the tumour microenvironment using carboplatin to enhance the efficacy of CAR T cell therapy for prostate cancer
  • 2023

    Journal article

    TSTEM-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models
    DOI: 10.1126/scitranslmed.abk1900

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224